share_log
Benzinga ·  07/09 07:57

Mainz Biomed Shares Are Trading Higher After the Company Announced the Submission for FDA Breakthrough Device Designation for Its CRC Screening Test

Mainz Biomed股票上涨,该公司宣布为其CRC筛查测试提交FDA突破性设备认定申请。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发